Critical-care studies: redefining the rules
- 1 October 1998
- journal article
- Published by Elsevier in The Lancet
- Vol. 352 (9136) , 1306-1307
- https://doi.org/10.1016/s0140-6736(98)02342-3
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Reversal of late septic shock with supraphysiologic doses of hydrocortisoneCritical Care Medicine, 1998
- Glucocorticoid treatment of sepsis and acute respiratory distress syndromeCritical Care Medicine, 1998
- A Trial of Goal-Oriented Hemodynamic Therapy in Critically Ill PatientsNew England Journal of Medicine, 1995
- Elevation of Systemic Oxygen Delivery in the Treatment of Critically Ill PatientsNew England Journal of Medicine, 1994
- Recombinant Human Interleukin 1 Receptor Antagonist in the Treatment of Patients With Sepsis SyndromeJAMA, 1994
- Early treatment with parenteral penicillin in meningococcal disease.BMJ, 1992
- Definitions for Sepsis and Organ Failure and Guidelines for the Use of Innovative Therapies in SepsisChest, 1992
- Interleukin-1 receptor blockade improves survival and hemodynamic performance in Escherichia coli septic shock, but fails to alter host responses to sublethal endotoxemia.Journal of Clinical Investigation, 1992
- A Controlled Clinical Trial of High-Dose Methylprednisolone in the Treatment of Severe Sepsis and Septic ShockNew England Journal of Medicine, 1987
- The Effects of High-Dose Corticosteroids in Patients with Septic ShockNew England Journal of Medicine, 1984